All Episodes – Page 9
Browse our complete library of interviews and discussions with leading experts in oncology.

Rivaroxaban Confirmed as Oral Alternative For Cancer Thromboembolism
ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe
5 February 2018
15 min